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http://dx.doi.org/10.1016/j.ccr.2014.06.003Impaired perfusion is a hallmark of solid
tumors that promotes progression, immu-
nosuppression, and treatment resistance
and is partly caused by vascular com-
pression from excessive extravascular
stresses (Chauhan et al., 2013; Styliano-
poulos et al., 2012). The extravascular
stress exerted by fluid is referred to as
interstitial fluid pressure (IFP) and that
by solid components as solid stress (SS).
IFP is near zero in most tissues, but rises
in tumors as impaired lymphatics fail to
drain fluid leaking from blood vessels and
IFP equilibrates with microvascular pres-
sure (MVP) (Boucher and Jain, 1992). Due
to equilibration, IFP in tumors can only
transiently exceed MVP and thus cannot
compress tumor vessels (Figure S1A
available online). SS is generated as
cells push and pull on their surroundings
during proliferation and migration and is
transmitted by extracellular matrix (Stylia-
nopoulos et al., 2012). SS is greatly and
chronically elevated in tumors due to
high cell and matrix densities and can
compress blood vessels (Figure S1A).
Since the causes and consequences of
elevated IFP and SS are different, strate-
gies for alleviating these mechanical
stresses are likely to be distinct.
In their article, Provenzano et al.
elegantly showed that hyaluronan (HA)
can mechanically compress blood ves-
sels in pancreatic ductal adenocarcinoma
(PDA) (Provenzano et al., 2012). However,
their proposed mechanism—that HA
leads to very high IFP that collapses
vessels—is not consistent with the physi-
ology of fluid homeostasis and calls for14 Cancer Cell 26, July 14, 2014 ª2014 Elsevcareful assessment of IFP in PDAs. They
suggest that mean IFP can reach
99 mmHg (range 75–130 mmHg), pre-
sumably higher than MVP, in the Pdx1-
Cre/KrasLSL-G12D/+/p53LSL-R172H/+ (KPC)
PDA model based on measurements
made with a piezoelectric probe. To eval-
uate this, we measured IFP in KPC
tumors with the wick-in-needle tech-
nique—which has been validated against
the gold-standard micropipette technique
(Boucher and Jain, 1992). We further
measured IFP in additional PDA models,
Ptf1-Cre/KrasLSL-G12D/+/p53L/+ (KPdC)
and Ptf1-Cre/ROSA26-LSL-rtTA-IRES-
GFP/KrasTetO-LSL-G12D/+/p53L/+ (iKPdC),
which highly express HA (Figure S1B).
The mean IFP was 8.1 mmHg (range
4.7–10.9 mmHg) in KPC, 3.4 mmHg
(range 1.6–5.6 mmHg) in KPdC, and
6.7 mmHg (range 6.1–8.0 mmHg) in
iKPdC (Figure S1C)—over an order of
magnitude lower than the IFP levels re-
ported by Provenzano et al. We also
measured IFP with wick-in-needle in the
tumors of four treatment-naive PDA pa-
tients (Figure S1C), and the mean IFP
was 11.8 mmHg (range 6.1–16.6 mmHg).
As these IFPs do not exceed typical
MVPs, IFP cannot compress PDA ves-
sels, leaving SS as the primary cause.
Provenzano et al. also propose that
PDA IFP is not driven by equilibration
with MVP because PDA vessels are non-
leaky, i.e., nonpermeable to macromole-
cules. As evidence, they state that PDA
IFP measured with the piezeoelectric
probe remains elevated upon cardiac
cessation, indicating that blood pressureier Inc.is not driving IFP. With wick-in-needle,
we found that cardiac cessation reduced
IFP to zero in all three PDA models,
confirming that blood pressure drives
elevated IFP (Boucher and Jain, 1992).
Furthermore, their hypothesis that PDA
vessels are nonpermeable to macro-
molecules is contradicted by their
own data—PEGylated recombinant hu-
man hyaluronidase (PEGPH20), a macro-
molecule, clearly permeates across PDA
vessels since it acts on interstitial HA.
Moreover, the efficacy in PDA patients of
nanoparticle-albumin-bound-paclitaxel,
an FDA-approved macromolecule, also
indicates that PDA vessels are somewhat
leaky. We conclude that PDA IFP is
indeed driven by blood pressure and
that fluid exchange between the intravas-
cular and interstitial space in PDA facili-
tates equilibration of IFP and MVP as in
other tumors.
The discrepancy between our IFP
measurements and those of Provenzano
et al. may stem from their use of the
piezoelectric probe technique (Ozerdem
and Hargens, 2005), which we believe
suffers from artifacts coming from
SS. As evidence for our hypothesis,
Provenzano et al. measured an IFP of
10.4 mmHg (range 8–13 mmHg) in
normal mouse pancreata, although
normal murine tissues typically have
slightly negative IFPs. Ozerdem and Har-
gens tested this technique against wick-
in-needle in a single tumor model in
two mice, but they did not carefully
test for such artifacts—for example by
comparison to wick-in-needle in tissues
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therefore compared the piezoelectric
probe technique to wick-in-needle in
multiple normal murine tissues. We found
that the piezoelectric probe produces
significantly higher measurements when
compared with wick-in-needle (Figures
S1D and S1E). For example, we
measured pancreas IFP as 0.7 mmHg
(range 0.9 to 0.5 mmHg) with wick-
in-needle, whereas our pancreas
measurements with the piezoelectric
probe were 9.8 mmHg (range 8.5–
11.3 mmHg). This discrepancy most
likely occurs because the sensor in the
piezoelectric probe, unlike that in wick-
in-needle, directly contacts cells and ma-
trix allowing solid tissue components to
contribute to the reading. We conclude
that the piezoelectric probe method
developed by Ozerdem and Hargens—
and used by Provenzano et al.—mea-
sures pressures that are higher than theactual IFP due to artifacts from solid
tissue components.
As demonstrated here, HA-rich desmo-
plasia in PDA does not produce unusually
high IFP, IFP cannot compress PDA
vessels, and the technique Provenzano
et al. used to measure IFP actually mea-
sures a combination of IFP and SS.Mean-
while, we found that HA increases SS
through storage and transmissionmecha-
nisms (Stylianopoulos et al., 2012). Thus,
PEGPH20 most likely reduces SS,
thereby decompressing vessels. Since
IFP cannot compress blood vessels, we
propose that the mechanism of vessel
decompression by PEGPH20 is solely a
reduction in SS. Importantly, therapies
that alleviate SS cause decompression
of vessels and improve PDA treatment
(Chauhan et al., 2013). Thus, we concur
that PEGPH20 has immense promise for
PDA, and we hope that this correspon-
dence clarifies its mechanism.Cancer CSUPPLEMENTAL INFORMATION
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